Vai al contenuto
Ora

In corsoGiorno 1

NSW September unauthorized-peptide emergency visits

  1. Aggiornamento 1 di 1UltimoGiorno 1

    NSW records 1,180 peptide-linked emergency visits amid warnings on online products

    Fifteen months of NSW surveillance show a sharp rise in emergency presentations associated with peptide use. The warning concerns unapproved products—not every peptide medicine.

    Guarda

    ABC listen

    • 1,180Emergency presentations over fifteen months
    • 5Presentations in July 2025
    • More than 217Presentations in September 2026
    • NSW recorded a sharp rise in emergency presentations associated with peptide use, alongside a ministerial warning about serious harm from unregulated products.
    • The surveillance does not identify the products involved, their verified contents, the number of distinct patients or how many suffered lasting injury.
    • Product-specific findings, fuller surveillance definitions and patient outcomes would show more clearly what is driving the increase. No date has been announced for the next surveillance release.

Chi ne ha riferito

Chi ne ha riferito

11 testate · 25 fonti · 1 video

A questo punto, 4 fonti su 11 avevano pubblicato

Chi è coinvolto

Chi è coinvolto

Organizzazioni

  • Ministry of Healthministry in New South Wales, Australia
  • Therapeutic Goods Administrationregulatory body for therapeutic goods (including medicines, medical devices, gene technology, and blood products) in Australia

Luoghi

  • New South Wales